Page 5 - Best hematologist-oncologists: TOP 170 doctors

Professor Dina Ben-Yehuda pioneered gene therapy and bone marrow transplants at Hadassah Medical Center – Israel's leading hematology department.

• Head of Hematology with 34 years of experience of experience
• Trained at Memorial Sloan-Kettering Cancer Center in New York
• First female Dean of Hadassah School of Medicine
• Recipient of the Healing with the Heart Award for exceptional patient care
• Specializes in molecular diagnostics for blood cancers

Recognized by Forbes as one of the best doctors in 2018 – Dr. Stepensky has performed over 3,500 bone marrow transplants at Hadassah Medical Center.

• 28 years of experience specializing in pediatric bone marrow transplants
• Focused on rare blood cancer diseases in children
• Known among patients as 'the one who transplants life'
• Leads a dedicated pediatric hematology unit

Dr. Irina Zaidman specializes in pediatric bone marrow transplantation, trained at top institutions worldwide including Toronto's Hospital for Sick Children.

• Board member of the Israeli Pediatric Hemato-Oncology Society
• Active in teaching and research on pediatric transplants
• Member of European and American BMT societies
• Published multiple articles on pediatric bone marrow transplants

Prof. Elad Jacoby, MD, heads the Pediatric Cell Therapy Center at Sheba Medical Center. He is the Medical Director of the Advanced Biotherapy Center. He is a pioneer of pediatric CAR T‑cell therapy in Israel. He led one of the first national leukemia programs. He has almost 20 years of clinical and research experience.

He specializes in CAR T‑cell therapy, bone marrow and stem cell transplantation, and high‑risk pediatric leukemias and lymphomas. He leads international clinical trials and has authored over 240 publications. His collaborations include Johns Hopkins Hospital and the U.S. National Cancer Institute. He is an Associate Professor at Tel Aviv University. He received his MD from Tel Aviv University, completed residency at Sheba Medical Center, and fellowships at Johns Hopkins and the National Cancer Institute. He is board‑certified in Pediatrics and in Pediatric Hematology and Oncology. He serves on the IBFM CAR T‑Cell Taskforce and the Sheba Institutional Review Board. He leads the integration of CAR T‑cell therapy with transplantation.

Dr. Iris Kventsel, MD, is a pediatric hemato-oncologist and bone marrow transplant (BMT) specialist at Sheba Medical Center. She is an attending physician in the Pediatric Hemato-Oncology and BMT Division at the Edmond and Lily Safra Children’s Hospital. Her clinical focus is pediatric sarcomas, including Ewing sarcoma, osteosarcoma, and rhabdomyosarcoma.

She provides multidisciplinary care, including transplant and cellular therapies. She also uses current chemotherapy protocols and targeted therapies for complex childhood cancers.

Her research focuses on genetic cancer predisposition, including Li-Fraumeni syndrome, and cancer susceptibility genes. She has published in pediatric oncology, stem cell biology, and surgical oncology (HIPEC). She is on the academic staff at Tel Aviv University. Education: MD, Technion; Pediatrics residency, Assaf HaRofeh; Pediatric Hemato-Oncology fellowship, Sheba.

Dr. Ofer Spielberg is an oncohematologist at Assuta Medical Center, specializing in blood cancers like lymphoma and leukemia.

• Focuses exclusively on hematologic malignancies and complex blood disorders
• Expert in bone marrow transplantation and modern treatment protocols
• Provides personalized care at Israel's leading private hospital

Deputy head of the Pediatric Hematology Department at Rambam Medical Center – specializes in pediatric blood disorders and cancers.

• of experience in pediatric hematology
• Focuses on treating childhood leukemias and lymphomas
• Participates in research for innovative pediatric treatments
• Works within one of Israel's leading medical centers

Dr. Hila Magen, MD, leads the Multiple Myeloma and Amyloidosis Unit at Sheba Medical Center. She is a hemato-oncologist with over 35 years of experience. She is a leading Israeli expert in multiple myeloma and plasma cell disorders.

She runs a program that provides personalized care and early access to clinical trials. This includes CAR-T therapy for high-risk and relapsed or refractory myeloma and amyloidosis. Dr. Magen is a principal investigator in point-of-care CAR-T studies. She brings new immunotherapies into routine care.

Training: Fellowships in Multiple Myeloma (UAMS) and Lymphocytic Leukemia (MD Anderson). Academic: Instructor, Tel Aviv University. Research: Author of 100+ publications, contributor to landmark myeloma studies, and reviewer for international journals.

Dr. Abraham Avigdor, MD, is Director of the Institute of Hematology and Co‑Director of the Hematology & Bone Marrow Transplantation Division at Sheba Medical Center. He is an international leader in lymphoma, CAR‑T, and advanced hemato‑oncology with more than 35 years of experience. His clinical focus includes lymphomas, multiple myeloma, and complex blood cancers.

He is a pioneer in CAR‑T integration. He leads cellular therapy and bone marrow transplantation programs (autologous and allogeneic). He also advances stem cell therapies and precision diagnostics, including PET/CT‑based prognostics. His work includes immunotherapy and targeted regimens and the development of innovative, data‑driven protocols.

He collaborates with LYSA, EMCL, and international PET groups. He has authored more than 130 publications. Key roles include Founder and President of the Israeli Lymphoma Working Group, former Chair of the Israeli Lymphoma Study Group, and Senior Lecturer at Tel Aviv University. Education: MD, Ben‑Gurion University; residency, Sheba Medical Center; postdoctoral fellowship, Weizmann Institute. Awards include the Knesset Prize, the Israeli Ministry of Health Award, and the Sackler Prize.

Prof. Avichai Shimoni, MD, is Director of Bone Marrow Transplantation at Sheba Medical Center. He is a hemato-oncologist with over 30 years of experience in bone marrow transplantation, cellular therapies, and advanced blood cancer care.

He leads a high-volume program for complex, high-risk blood cancers. He performs allogeneic and autologous transplants. He also provides CAR T-cell therapy for leukemia, lymphoma, and multiple myeloma. He completed a bone marrow transplantation fellowship at MD Anderson Cancer Center.

He is Chairman of Hematology at Tel Aviv University and a Professor of Hematology. He has authored more than 250 scientific papers. His research focuses on CAR T-cell therapy and stem cell transplantation. He is often listed among Israel's Best Doctors (Forbes 2025 and 2026).

Specialist in radiotherapy for oncology, focusing on treating cancer patients with radiation at Rambam Medical Center.

• Specializes in using radiotherapy to treat cancers, including lymphoma and leukemia
• Combines expertise in both radiation and medical oncology for patient care
• Focuses on personalized treatment plans for Hodgkin's lymphoma
• Uses advanced radiotherapy techniques for precise cancer treatment

Professor Zila Zuckerman specializes in hematology and bone marrow transplantation – a senior physician at Rambam Medical Center, Israel's leading hospital.

• Focuses on advanced transplant protocols for blood cancers
• Over of experience in hematology and transplantology
• Professor with deep academic and clinical expertise
• Leads a specialized hematology and transplantology unit

Dr. Ozden Gul specializes in surgical oncology with expertise in minimally invasive techniques, ensuring quicker recovery and minimal scarring for patients.

• Trained at Istanbul University Cerrahpaşa – one of Turkey's top medical schools
• Specializes in gastrointestinal, endocrine, and breast cancer surgeries
• Fluent in English, facilitating clear communication with international patients
• Worked at leading hospitals including Haydarpaşa Numune Training and Research Hospital

Head of Italy's largest bone marrow transplant program – Dr. Peccatori oversees 90+ allogeneic transplants yearly at San Raffaele.

• 29 years of experience leading the Bone Marrow Transplant Unit
• Published 70+ studies on transplantation and hematologic cancers
• Specializes in lymphoma and complex transplant cases
• Member of European Society for Blood and Marrow Transplantation

65+ scientific articles on hematology – Prof. Omay leads bone marrow transplantation research at Emsey Hospital with training from Japan's Mie Medical School.

• Specializes in stem cell transplants for leukemia and lymphoma
• Professor of hematology at Ege and Karadeniz Technical Universities
• Published 112 meeting papers and presented at 34 international conferences
• Head of Hematology Department with 36 years of experience of experience